tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Soumit Roy, 72 are a BUY (85.71%), 1 are a SELL (1.19%), 11 are a HOLD (13.1%).
Analyst Soumit Roy, currently employed at JONESTRADING, carries an average stock price target met ratio of 29.53% that have a potential upside of 24.53% achieved within 85 days.
Soumit Roy’s has documented 155 price targets and ratings displayed on 32 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ELVN, Enliven Therapeutics at 25-Mar-2026.
Analyst best performing recommendations are on CGEM (CULLINAN ONCOLOGY LLC).
The best stock recommendation documented was for CGEM (CULLINAN ONCOLOGY LLC) at 4/16/2024. The price target of $26 was fulfilled within 13 days with a profit of $8.68 (50.12%) receiving and performance score of 38.55.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 31-Oct-2023
$23
$-2.59 (-10.12%)
$23
2 years 5 months 20 days ago
(10-May-2024)
5/8 (62.5%)
$-2.36 (-9.31%)
108
Sell Since 01-Mar-2022
$26
$0.41 (1.60%)
2 years 6 months ago
(30-Apr-2024)
2/7 (28.57%)
$0.73 (2.89%)
324
Buy Since 30-Apr-2024
$22
2 years 6 months ago
(30-Apr-2024)
2/3 (66.67%)
$2.24 (11.34%)
67
Buy Since 29-Apr-2024
$25.6
$0.01 (0.04%)
2 years 6 months 1 days ago
(29-Apr-2024)
0/1 (0%)
$0.32 (1.27%)
Buy Since 29-Apr-2024
$23
2 years 6 months 1 days ago
(29-Apr-2024)
1/2 (50%)
$11.07 (92.79%)
182
What Year was the first public recommendation made by Soumit Roy?
